Implementation Guide CH VACD
5.0.0 - trial-use
This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization TCA01-IMMUN3-HCP2-ORG2-ROLE
Author of the content: PractitionerRole
CH VACD Extension Immunization Medication Reference: Medication FSME-IMMUN CC Inj Susp sep Nadel
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/7f7a308a-63f7-4be1-a329-0a33e08b4645
status: Completed
vaccineCode: FSME-Immun CC
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-08-01
recorded: 2021-08-02 00:00:00+0200
lotNumber: 12-34244
route: Intramuscular use
Actor |
PractitionerRole |
note: Der Patient hatte keinerlei Nebenwirkungen. (By Practitioner/TC-HCP2-C2 @2021-08-01)
TargetDisease | DoseNumber[x] |
Tickborne encephalitis | 1 |